Last reviewed · How we verify

NCT06170463

Insulin Sensitizers Role in Control of PCOS Vicious Cycle.

Completed Phase 1 Last updated 20 December 2023
What this trial tests

Phase 1 trial testing Metformin Hydrochloride in PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries in 210 participants. Completed in 15 April 2023.

Timeline
1 August 2022
Primary endpoint
1 March 2023
15 April 2023

Quick facts

Lead sponsorZagazig University
PhasePhase 1
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment210
Start date1 August 2022
Primary completion1 March 2023
Estimated completion15 April 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Zagazig University

Who can join

Adults 18 to 45, female only, with PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

PCOS is a common and complex disease affecting women of reproductive age. It is characterized by its complex pathological symptoms and mechanisms resulting in endocrine and metabolic dysfunction. PCOS is highly associated with various metabolic and endocrinal disorders. Metformin is mainly used for its glucose-lowering effects for treatment and prevention of type-2 diabetes mellitus (DM), gestational DM, and PCOS. Myo-inositol (MI) protects against MAFLD through reduction of hepatic accumulation of triglycerides.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Metformin Hydrochloride

Trials testing the same drug.

Other recruiting trials for PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

Currently open trials in the same condition.

Other Zagazig University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06170463.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing